sumatriptan has been researched along with Headache Disorders in 15 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Headache Disorders: Various conditions with the symptom of HEADACHE. Headache disorders are classified into major groups, such as PRIMARY HEADACHE DISORDERS (based on characteristics of their headache symptoms) and SECONDARY HEADACHE DISORDERS (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Migraine is a very common disorder." | 2.42 | [Pitfall in migraine treatment]. ( Araki, N, 2003) |
| "Headache disorders are highly prevalent and debilitating, with limited treatment options." | 1.56 | Low-dose interleukin-2 reverses behavioral sensitization in multiple mouse models of headache disorders. ( Cao, YQ; Cloud, ME; Czerpaniak, K; Hotchkiss, RS; Huang, L; Li, D; Liu, X; Unsinger, J; Zhang, J, 2020) |
| "41." | 1.46 | Clinical characteristics and overuse patterns of medication overuse headache: Retrospective case-series study. ( Kluonaitis, K; Petrauskiene, E; Ryliskiene, K, 2017) |
| "Among migraineurs, triptan consumers reported more frequent and severe headaches than non-consumers, and reported a higher incidence of nausea and vomiting." | 1.32 | Use and misuse of triptans in France: data from the GRIM2000 population survey. ( Auray, JP; Chazot, G; Dartigues, JF; Duru, G; El Hasnaoui, A; Gaudin, AF; Henry, P; Lantéri-Minet, M; Lucas, C; Pradalier, A, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, J | 1 |
| Czerpaniak, K | 1 |
| Huang, L | 1 |
| Liu, X | 1 |
| Cloud, ME | 1 |
| Unsinger, J | 1 |
| Hotchkiss, RS | 1 |
| Li, D | 1 |
| Cao, YQ | 1 |
| Kluonaitis, K | 1 |
| Petrauskiene, E | 1 |
| Ryliskiene, K | 1 |
| Moye, LS | 1 |
| Tipton, AF | 1 |
| Dripps, I | 1 |
| Sheets, Z | 1 |
| Crombie, A | 1 |
| Violin, JD | 1 |
| Pradhan, AA | 1 |
| Rapoport, AM | 1 |
| Carpay, JA | 1 |
| Linssen, WH | 1 |
| Koehler, PJ | 1 |
| Arends, LR | 1 |
| Tiedink, HG | 1 |
| Lucas, C | 1 |
| Auray, JP | 1 |
| Gaudin, AF | 1 |
| Dartigues, JF | 1 |
| Duru, G | 1 |
| Henry, P | 1 |
| Lantéri-Minet, M | 1 |
| Pradalier, A | 1 |
| Chazot, G | 1 |
| El Hasnaoui, A | 1 |
| Araki, N | 1 |
| Søndergaard, J | 1 |
| Foged, A | 1 |
| Kragstrup, J | 1 |
| Gaist, D | 1 |
| Gram, LF | 1 |
| Sindrup, SH | 1 |
| Muckadell, HU | 1 |
| Larsen, BO | 1 |
| Herborg, H | 1 |
| Andersen, M | 1 |
| Prusiński, A | 1 |
| Rothner, AD | 1 |
| Evers, S | 1 |
| Husstedt, IW | 1 |
| Cady, R | 1 |
| Evans, RW | 1 |
| Robbins, L | 1 |
| Goadsby, PJ | 1 |
| Akerman, S | 1 |
| Storer, RJ | 1 |
5 reviews available for sumatriptan and Headache Disorders
| Article | Year |
|---|---|
New acute treatments for headache.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Botulinum Toxins, Type A; Clinical Trials as Topic; Diclofe | 2010 |
[Pitfall in migraine treatment].
Topics: Contraindications; Headache Disorders; Humans; Meta-Analysis as Topic; Migraine Disorders; Randomize | 2003 |
[Drug rebound headaches].
Topics: Adult; Analgesics; Antidepressive Agents; Antidepressive Agents, Tricyclic; Drug Administration Sche | 1999 |
Headaches in children and adolescents: update 2001.
Topics: Adolescent; Analgesics; Arnold-Chiari Malformation; Child; Diagnosis, Differential; Female; Headache | 2001 |
Efficacy of sumatriptan in chronic paroxysmal hemicrania.
Topics: Adult; Chronic Disease; Female; Headache Disorders; Humans; Middle Aged; Serotonin Receptor Agonists | 1998 |
2 trials available for sumatriptan and Headache Disorders
| Article | Year |
|---|---|
Efficacy of sumatriptan nasal spray in recurrent migrainous headache: an open prospective study.
Topics: Administration, Inhalation; Adult; Female; Headache Disorders; Humans; Male; Migraine Disorders; Pro | 2003 |
Intensive community pharmacy intervention had little impact on triptan consumption: a randomized controlled trial.
Topics: Adult; Denmark; Drug Prescriptions; Drug Utilization; Education, Pharmacy, Continuing; Female; Heada | 2006 |
8 other studies available for sumatriptan and Headache Disorders
| Article | Year |
|---|---|
Low-dose interleukin-2 reverses behavioral sensitization in multiple mouse models of headache disorders.
Topics: Animals; Headache Disorders; Interleukin-2; Mice; Migraine Disorders; Nitroglycerin; Sumatriptan | 2020 |
Clinical characteristics and overuse patterns of medication overuse headache: Retrospective case-series study.
Topics: Adult; Analgesics; Analgesics, Opioid; Female; Headache Disorders; Headache Disorders, Secondary; Hu | 2017 |
Delta opioid receptor agonists are effective for multiple types of headache disorders.
Topics: Animals; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Headache Diso | 2019 |
Use and misuse of triptans in France: data from the GRIM2000 population survey.
Topics: Adult; Chi-Square Distribution; Female; France; Headache Disorders; Health Surveys; Humans; Male; Mi | 2004 |
Headache due to antimigraine 5HT1 receptor agonists.
Topics: Analgesics; Headache; Headache Disorders; Humans; Indoles; Oxazolidinones; Piperidines; Prospective | 1999 |
Looking forward: the expanding utility of sumatriptan and naratriptan.
Topics: Headache Disorders; Humans; Indoles; Migraine Disorders; Piperidines; Primary Health Care; Serotonin | 2001 |
Daily triptans for headache.
Topics: Drug Administration Schedule; Female; Headache Disorders; Humans; Middle Aged; Serotonin Receptor Ag | 2001 |
Evidence for postjunctional serotonin (5-HT1) receptors in the trigeminocervical complex.
Topics: Animals; Brain; Cats; Cervical Plexus; Electric Stimulation; Ergonovine; Excitatory Amino Acid Agoni | 2001 |